Kate Lyden

Kate Lyden, PhD is Chief Science Officer at VivoSense, where she leads scientific strategy, digital endpoint development, and clinical validation of wearable-derived measures used in global clinical trials. She brings extensive experience spanning academic research, industry, and regulatory-facing evidence generation, with deep expertise in translating continuous real‑world sensor data into clinically meaningful and regulatory‑grade endpoints. Kate has authored numerous peer‑reviewed publications on objective measurement of human behavior and is a frequent contributor to industry working groups and clinical development forums focused on digital health technologies.

Ruth Lux

Ruth Lux is a global leader in climate and disaster risk finance and a member of the Operating Committee of the Insurance Development Forum (IDF), where she also serves as Co-Chair of the Sovereign & Humanitarian Solutions Working Group.

Until March 2025, Ruth headed the Public Sector Solutions practice for UK, Europe, India, Middle East & Africa at Guy Carpenter, advising governments, multilateral agencies, and public entities on climate resilience, sovereign and sub-sovereign risk financing, and the integration of insurance into development and fiscal policy. She has also worked extensively with multilateral development banks, NGOs, and the private sector, helping bring together diverse partners to pioneer new models of disaster risk financing and resilience-building. She additionally serves on the Advisory Group of the Start Network’s Risk Pooling and Risk Financing initiative, which is scaling innovative approaches to anticipatory humanitarian action.

She has played a leading role in the design and implementation of innovative insurance and risk transfer programmes, including parametric drought and flood solutions, macro-level climate facilities, and sovereign catastrophe financing strategies across Africa, Latin America, Asia, and Europe.

Earlier in her career, Ruth founded and ran a political risk consultancy advising corporates and government agencies, and headed political and terrorism risk analytics at JLT Specialty.

Ruth holds an MSc in International Relations from the London School of Economics, a BA in French and Spanish from the University of Bristol, and is fluent in French and Spanish.

Himanshu Sahu

Himanshu Sahu is a Clinical Data Management Specialist at Nestle Clinical Research Unit with over 16 years of experience leading end‑to‑end clinical data management across global pharmaceutical and nutrition research. He is known for his expertise in data quality oversight, cross‑functional study leadership, and driving data‑strategy initiatives in collaboration with CROs and external service providers. A strong advocate of data storytelling, he leverages tools like Power BI to translate complex clinical data into actionable insights. His career includes key roles at Novartis, AstraZeneca, Alcon, Iqvia, and Cognizant, where he championed process optimization and innovation in data workflows. Himanshu holds an MSc in Biotechnology and a Postgraduate Certificate in Clinical Research & Data Management and is widely recognized for his strategic thinking and commitment to advancing data‑driven excellence in clinical research.

Denis Pertsev

Denis Pertsev is CEO of Intelligent Solutions Finland Oy and holds a Master of Science in Artificial Intelligence, bringing over 25 years of experience in IT and digital transformation. He works directly with large-scale digital projects for governments and enterprises across the Nordic region. Intelligent Solutions Finland Oy serves as the primary technology partner of the Government of the Faroe Islands, delivering production-ready solutions including a Digital Government Platform, Government Digital Wallet, and Business Register.

Prior to his current role, Denis served as Lead Architect in the banking sector, working with Giesecke & Devrient on core banking system design for the South American market.

Today, Denis focuses on driving AI adoption and innovation within enterprises. In partnership with two European universities, Intelligent Solutions Finland Oy actively participates in R&D, bridging cutting-edge research with practical implementation — including custom deep learning (DNN and CNN) solutions deployed in production environments..

Aiden Knight

Since joining GlobalData Strategic Intelligence as an associate analyst in the 2024 graduate intake, Aidan has written reports on artificial intelligence (AI), the internet of things (IoT), cloud computing, future of work technologies, and geopolitics within the mining, defense, and financial services sectors. In Aidan’s most recent reports, he explores the impact of blockchain and AI on the banking, payments, wealth management, and insurance sectors, discussing potential risks to FS firms that do not develop their own strategies. He explores topics like anti-money laundering (AML), agentic AI, cybersecurity, fraud prevention, know-your-customer (KYC), Insider threats, and human error.

Natasha Crawley

Natasha Crawley is the Group Head of Risk & Compliance at ManyPets and an experienced solicitor with a background in roles at AXA UK and HSBC. She leads the organisation’s regulatory strategy, governance framework and risk management agenda, ensuring ManyPets operates with integrity while enabling innovation and growth.

Natasha is known for delivering clear, commercially‑focused advice that supports pragmatic decision‑making and strong customer outcomes. Her approach balances regulatory rigour with a deep understanding of business priorities.

Her work underpins ManyPets’ mission: to deliver pet insurance like no other — more supportive of pet parents, smarter in how technology is used, and committed to simpler, more forward‑thinking experiences.

She collaborates closely with regulators, industry peers and senior leaders to embed ethical, resilient and forward‑looking practices across the business.

James Daley

James Daley has been a consumer campaigner and financial journalist for over 25 years. Before launching Fairer Finance in 2014, he worked for the consumer group, ‘Which’, where he campaigned for a better deal for customers of banks and insurers in the wake of the financial crisis.

James is frequently interviewed on national television and radio, and has regularly appeared on shows such as Watchdog, Rip-off Britain, Dispatches and Moneybox.

Before working at Which?, James spent 10 years as a business and finance newspaper journalist, latterly as The Independent’s personal finance editor and cycling columnist.

James is a member of both UK Finance’s and the Association of British Insurers’ Consumer Advisory Groups. He was also previously a member of the Chartered Insurance Institute’s professional standards board and is an Honorary Alderman of the London Borough of Wandsworth having served as a councillor for 12 years.

He lives with his wife and two children in Tooting, where he’s also Chair of Governors at Smallwood Primary School.

Donna Copeland

Donna Copeland is a senior research operations leader with over 17 years’ experience working in NHS Clinical Research. She is currently a Research Manager at Imperial College Healthcare NHS Trust, where she provides end‑to‑end research business partnering to Clinical Divisions, supporting the development, set‑up and successful delivery of clinical research in the Trust.

Donna plays a key strategic role in bridging between researchers, and the various research and clinical support structures as well as her expertise in the NHS funding streams available helping our PIs and Delivery Teams to secure and optimise funds to deliver and grow their research.

A strong advocate for sustainable service improvement, Donna has led and contributed to multiple initiatives focused on improving study set‑up effectiveness and timelines, improving data quality and growing research capacity and capability. Her work is driven by a practical focus on delivering faster, simpler and fairer access to high‑quality research, providing an optimised delivery service to our patients, sponsors and PI delivery teams and ensuring patients benefit from timely participation and high-quality data collection in clinical research.”

Darren Grasby

Executive Vice President, Chief Sales Officer and President AMD EMEA